Temple Liver Disease Program
The Temple Liver Disease Program provides comprehensive medical and surgical treatment for patients with all forms of liver disease.
|Temple University Hospital Boyer Pavilion
||3509 N. Broad Street (Broad & Tioga Streets)
||Philadelphia, PA 19140
The Temple Liver Disease Program is distinguished by the presence of nationally recognized experts in liver disease. Our physicians and surgeons have a combined experience of many decades treating liver transplant patients and have performed well over 1000 liver transplant surgeries.
A Full Range of Sophisticated Therapies
Many patients coming to Temple have obscure, unresponsive, serious, or complicated forms of liver disease. Our patients often require highly specialized treatments such as:
- Aggressive drug and immune therapy for viral hepatitis and overlapping conditions
- Tailored combinations of drug, immune, and nutrition therapy with extra attention to monitoring and adjustments to minimize side effects while increasing compliance and efficacy in patients with hepatitis or cirrhosis
- Critical care for coagulopathy, encephalopathy, and other risks in acute liver failure
- Interventional radiologic procedures:
- Liver biopsy
- Bile duct drainage
- Portal vein embolization
- Arterial chemoembolization
- Yttrium therapies
- Radiofrequency and microwave ablation
- Transjugular intrahepatic portosystemic shunts (TIPS)
- Laparoscopic and other minimally invasive procedures:
- Liver biopsy
- Liver lobectomy or cyst removal
- Liver wedge resection
- Stent placements
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Complex major liver and pancreatic surgeries:
- Repair of bile duct injuries
- Liver and bile duct resections
- Radiofrequency ablation
- Whipple procedure and variations
ABDULLAH M. S. AL-OSAIMI, MD, FACP, FACG, AGAF, Chief of the Division of Hepatology and Medical Director of Liver Transplantation at Temple University Hospital, is one of the nation's leading clinicians, researchers and educators in the field of Hepatology and Liver Transplantation. He specializes in the treatment of hepatitis C and non-alcoholic fatty liver disease, including liver transplantation in these populations, as well as autoimmune and cholestatic liver disorders.
VISHAL PATEL, MD served his residency at Lehigh Valley Hospital in Allentown, PA and completed his Hepatology fellowship at Albert Einstein Medical Center in Philadelphia. His clinical interests include management of viral hepatitis, autoimmune liver disease, end stage liver disease including complications of portal hypertension and acute liver failure.
ANTONIO DI CARLO, MD, CM, FACS, FRCSC, Chief of Abdominal Organ Transplant Surgery at Temple University Hospital, is a specialist in hepatobiliary surgery and liver, kidney and pancreas transplantation. Dr. Di Carlo is recognized for his ability to provide patients with laparoscopic versions of liver resection and other procedures. He is also acknowledged for his expertise in treating hepatocellular cancer in patients with and without liver failure and has been invited to lecture on the topic by numerous organizations.
ASHOKKUMAR JAIN, MD, Surgical Director of Liver Transplant Program, is internationally known as one of the most experienced liver transplant and hepatobiliary surgeons. Since his training at the University of Pittsburgh, he has performed more than 1,000 liver transplants. Over the last two decades, he has published over 250 manuscripts and presented almost 600 scientific papers in national and international meetings. Dr. Jain brings unparalleled experience and new insights to the Liver Disease Program.
ANDREAS KARACHRISTOS, MD, PhD, Co-Director of the Temple Liver Tumor Program, is experienced in a full range of hepatobiliary surgical procedures to meet the special needs of diverse patients. He employs both open and laparoscopic approaches to address problems of the liver and bile duct. Dr. Karachristos also performs liver transplantation and surgery for primary and metastatic liver tumors — including the resectioning of liver tumors to allow patients to meet transplant eligibility.
KELVIN KWAN N. LAU, MD, comes to Temple from the Pfleger Liver Institute at the Dumont-UCLA Liver Transplant Center in California, where he completed a fellowship in multi-organ transplantation. An avid researcher, Dr. Lau has over twenty publications to his credit, including journal articles, abstracts and book chapters.
Interventional Radiology & Oncology
GARY S. COHEN, MD, is Chief of Vascular/Interventional Radiology, Co-Director of the Liver Tumor Program, and Professor and Vice Chair of Radiology. He has been consistently selected as a “TOP DOC” in Philadelphia magazine is nationally recognized for his interventional expertise. His interests include all facets of liver diagnosis and intervention from percutaneous biliary drainage and stenting to cutting-edge IPS endografts, percutaneous portal vein embolization en route to tumor resection, and percutaneous interventional oncology including chemoembolization, Yttrium therapies, radio frequency ablation, and microwave ablation.
To schedule an appointment with a physician from the Temple Liver Disease Program, call 1-800-TEMPLE-MED (800-836-7536).